Harvard Bioscience to attend Benchmark’s 9th Annual Discovery One-on-One Conference

Rhea-AI Summary

Harvard Bioscience (Nasdaq: HBIO) will participate in The Benchmark Company’s 9th Annual Discovery One-on-One Conference on November 18, 2020. CEO Jim Green and CFO Michael Rossi will engage in virtual meetings throughout the day. Interested investors can schedule a meeting by contacting their Benchmark representative or directly reaching out to Vince Curatola. Presentation materials will be available on the company’s investor relations page that same day at 8:00 AM ET. Harvard Bioscience specializes in technologies for drug development and serves a wide range of global customers.

HOLLISTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will participate in The Benchmark Company’s 9th Annual Discovery One-on-One Conference. The virtual event will take place on Wednesday, November 18, 2020 with virtual investor meetings held throughout the day. 

To schedule a meeting with management, please contact your Benchmark Company representative or Vince Curatola at vcuratola@benchmarkcompany.com or nyc@clearthink.capital.

A copy of the materials to be presented at the conference will be available on the investor relations page of the Harvard Bioscience website on November 18, 2020 at 8:00 AM ET.

About Harvard Bioscience

Harvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Our customers range from renowned academic institutions and government laboratories, to the world’s leading pharmaceutical, biotechnology and clinical research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.

For more information, please visit our website at www.harvardbioscience.com.

For investor inquiries, please contact Michael A. Rossi, Chief Financial Officer at (508) 893-8999.

FAQ

When is Harvard Bioscience participating in The Benchmark Company's conference?

Harvard Bioscience will participate in The Benchmark Company's 9th Annual Discovery One-on-One Conference on November 18, 2020.

Who from Harvard Bioscience will attend the 9th Annual Discovery One-on-One Conference?

Jim Green, Chairman, President and CEO, and Michael Rossi, CFO, will attend the conference.

How can I schedule a meeting with Harvard Bioscience management during the conference?

To schedule a meeting, contact your Benchmark Company representative or Vince Curatola via email.

What time will the presentation materials from Harvard Bioscience be available?

The presentation materials will be available on the investor relations page of the Harvard Bioscience website at 8:00 AM ET on November 18, 2020.

What does Harvard Bioscience do?

Harvard Bioscience develops technologies for fundamental research, discovery, and pre-clinical testing for drug development, serving academic institutions and clinical research organizations worldwide.